Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors.

Autor: Lindberg S; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Theme Cancer, Department of Head, Neck, Lung and Skin Tumors, Karolinska University Hospital, Stockholm, Sweden. Electronic address: sara.lindberg@ki.se., Grozman V; Section of Thoracic Radiology, Department of Imaging and Physiology, Karolinska University Hospital, Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Karlsson K; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Section of Radiotherapy Physics and Engineering, Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden., Onjukka E; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Section of Radiotherapy Physics and Engineering, Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden., Lindbäck E; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Section of Radiotherapy Physics and Engineering, Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden., Jirf KA; Theme Cancer, Department of Head, Neck, Lung and Skin Tumors, Karolinska University Hospital, Stockholm, Sweden., Lax I; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Theme Cancer, Department of Head, Neck, Lung and Skin Tumors, Karolinska University Hospital, Stockholm, Sweden., Wersäll P; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Section of Radiotherapy, Department of Cancer, Karolinska University Hospital, Stockholm, Sweden., Persson GF; Section of Radiotherapy, Department of Oncology, Rigshospitalet, Copenhagen, Denmark; Department of Oncology, Herlev-Gentofte Hospital, Herlev, Denmark; Department of Clinical Medicine, Copenhagen University Hospital, Copenhagen, Denmark., Josipovic M; Section of Radiotherapy, Department of Oncology, Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, Copenhagen University Hospital, Copenhagen, Denmark., Khalil AA; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Møller DS; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Hoffmann L; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Knap MM; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark., Nyman J; Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden., Drugge N; Department of Therapeutic Radiation Physics, Sahlgrenska University Hospital, Gothenburg, Sweden., Bergström P; Department of Oncology, Northern Sweden University Hospital, Umeå, Sweden., Olofsson J; Department of Oncology, Northern Sweden University Hospital, Umeå, Sweden., Rogg LV; Department of Oncology, Oslo University Hospital, Oslo, Norway., Hagen RK; Department of Oncology, Oslo University Hospital, Oslo, Norway., Frøland AS; Department of Oncology, Oslo University Hospital, Oslo, Norway., Ramberg C; Department of Medical Physics, Oslo University Hospital, Oslo, Norway., Kristiansen C; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark., Jeppesen SS; Department of Oncology, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, University of Southern Denmark, Odense, Denmark., Nielsen TB; Laboratory of Radiation Physics, Odense University Hospital, Odense, Denmark., Lödén B; Oncology Department, Central Hospital in Karlstad, Karlstad, Sweden., Rosenbrand HO; Oncology Department, Central Hospital in Karlstad, Karlstad, Sweden., Engelholm S; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden., Haraldsson A; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden., Billiet C; Department of Radiation Oncology, Iridium Netwerk, Wilrijk, University of Antwerp, Antwerp, Belgium., Lewensohn R; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Theme Cancer, Department of Head, Neck, Lung and Skin Tumors, Karolinska University Hospital, Stockholm, Sweden., Lindberg K; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Theme Cancer, Department of Head, Neck, Lung and Skin Tumors, Karolinska University Hospital, Stockholm, Sweden.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2023 Dec 01; Vol. 117 (5), pp. 1222-1231. Date of Electronic Publication: 2023 Jul 08.

The HILUS-Trial-a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy.

Autor: Lindberg K; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Theme Cancer, Section of Head, Neck, Lung and Skin Tumours, Karolinska University Hospital, Stockholm, Sweden. Electronic address: karin.lindberg@ki.se., Grozman V; Section of Thoracic Radiology, Department of Imaging and Physiology, Karolinska University Hospital, Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Karlsson K; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Section of Radiotherapy Physics and Engineering, Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden., Lindberg S; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Theme Cancer, Section of Head, Neck, Lung and Skin Tumours, Karolinska University Hospital, Stockholm, Sweden., Lax I; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Section of Radiotherapy Physics and Engineering, Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden., Wersäll P; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Section of Radiotherapy, Department of Cancer, Karolinska University Hospital, Stockholm, Sweden., Persson GF; Section of Radiotherapy, Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Department of Oncology, Herlev-Gentofte Hospital, University of Copenhagen, Herlev, Denmark; Department of Clinical Medicine, Faculty of Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Josipovic M; Section of Radiotherapy, Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Khalil AA; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Moeller DS; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Nyman J; Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden., Drugge N; Department of Therapeutic Radiation Physics, Sahlgrenska University Hospital, Gothenburg, Sweden., Bergström P; Department of Oncology, Northern Sweden University Hospital, Umeå, Sweden., Olofsson J; Department of Oncology, Northern Sweden University Hospital, Umeå, Sweden., Rogg LV; Department of Oncology, Oslo University Hospital, Oslo, Norway., Ramberg C; Department of Medical Physics, Oslo University Hospital, Oslo, Norway., Kristiansen C; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark., Jeppesen SS; Department of Oncology, Odense University Hospital, Odense C, Denmark; Institute of Clinical Research, University of Southern Denmark, Odense C, Denmark., Nielsen TB; Laboratory of Radiation Physics, Odense University Hospital, Odense C, Denmark., Lödén B; Oncology department, Central Hospital in Karlstad, Karlstad, Sweden., Rosenbrand HO; Oncology department, Central Hospital in Karlstad, Karlstad, Sweden., Engelholm S; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden., Haraldsson A; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden., Billiet C; Department of Radiation Oncology, Iridium Kankernetwerk, Wilrijk (Antwerp), Belgium; Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk-Antwerp, Belgium., Lewensohn R; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Theme Cancer, Section of Head, Neck, Lung and Skin Tumours, Karolinska University Hospital, Stockholm, Sweden.

Publikováno v: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2021 Jul; Vol. 16 (7), pp. 1200-1210. Date of Electronic Publication: 2021 Apr 03.

Efficacy and safety of chemoradiotherapy plus immune checkpoint inhibitors for the treatment of locally advanced cervical cancer: a systematic review and meta-analysis.

Autor: Zhao, Zhihong, Ruan, Jian, Fang, Minjie, Liu, Jingwen, Liao, Guixiang

Publikováno v: Frontiers in Immunology; 2024, p1-10, 10p

Safety and efficacy of stereotactic body proton therapy for high-risk lung tumors.

Autor: McMillan, Matthew T.¹, Shepherd, Annemarie F.^1,2, Minglei Kang², Liyong Lin³, Shaverdian, Narek¹, Wu, Abraham J.¹, Gelblum, Daphna Y.¹, Ohri, Nitin^2,4, Lazarev, Stanislav^2,5, Lee Xu², Chhabra, Arpit M.^2,5, Hasan, Shaakir^2,4, Choi, J. Isabelle^1,2, Gomez, Daniel R.¹, Rimner, Andreas¹, Haibo Lin^1,2,4, Simone II, Charles B.^1,2 csimone@nyproton.com

Publikováno v: Journal of Radiosurgery & SBRT. 2023, Vol. 9 Issue 1, p63-74. 12p.

Proton SBRT is ready to move past uncertainties and towards improved clinical outcomes.

Autor: Simone II, Charles B.¹, Liyong Lin² liyong.lin@emoryhealthcare.org

Publikováno v: Journal of Radiosurgery & SBRT. 2023, Vol. 9 Issue 1, p3-6. 4p.